12.64
Eyepoint Pharmaceuticals Inc (EYPT) 最新ニュース
EyePoint Pharmaceuticals Inc (EYPT) Q3 2025 Earnings Report Prev - GuruFocus
EyePoint Pharmaceuticals Inc (EYPT) Q3 2025 Earnings Report Preview: What To Expect - Yahoo Finance
Levin Capital Strategies L.P. Has $179,000 Holdings in Eyepoint Pharmaceuticals, Inc. $EYPT - MarketBeat
EyePoint Pharmaceuticals Inc. stock outlook for YEARJuly 2025 Review & Weekly Breakout Watchlists - newser.com
Has EyePoint Pharmaceuticals Inc. formed a bullish divergenceJuly 2025 Trends & Weekly Return Optimization Alerts - newser.com
Measuring EyePoint Pharmaceuticals Inc.’s beta against major indicesMarket Movers & Technical Buy Zone Confirmation - newser.com
Can EyePoint Pharmaceuticals Inc. stock deliver surprise earnings beatQuarterly Earnings Report & Safe Entry Point Alerts - newser.com
Is EyePoint Pharmaceuticals Inc. (PV3B) stock positioned for secular growthShare Buyback & Consistent Growth Equity Picks - newser.com
Is EyePoint Pharmaceuticals Inc. stock ready for breakoutJuly 2025 PreEarnings & Real-Time Volume Trigger Notifications - newser.com
The 8.1% Return This Week Takes EyePoint Pharmaceuticals' (NASDAQ:EYPT) Shareholders Five-year Gains to 211% - 富途牛牛
How EyePoint Pharmaceuticals Inc. stock performs in high volatility markets - newser.com
EyePoint Announces Participation at Upcoming Investor Conferences - The Manila Times
EyePoint (NASDAQ: EYPT) to appear at Guggenheim, Stifel and Jefferies investor events - Stock Titan
What’s next for EyePoint Pharmaceuticals Inc. stock price2025 Big Picture & Real-Time Chart Breakout Alerts - newser.com
Should you wait for a breakout in EyePoint Pharmaceuticals Inc.Market Sentiment Summary & Daily Profit Focused Screening - newser.com
Will EyePoint Pharmaceuticals Inc. stock split attract more investorsShort Setup & Weekly Chart Analysis and Guides - newser.com
Will EyePoint Pharmaceuticals Inc. (PV3B) stock deliver compounding returnsPortfolio Performance Summary & Long-Term Capital Growth Ideas - newser.com
Is EyePoint Pharmaceuticals Inc. (PV3B) stock a buy before new product rollout - newser.com
Combining price and volume data for EyePoint Pharmaceuticals Inc.July 2025 Institutional & Fast Gain Stock Trading Tips - newser.com
EyePoint Pharmaceuticals (NASDAQ:EYPT) shareholder returns have been stellar, earning 212% in 5 years - simplywall.st
Eyepoint Pharmaceuticals (EYPT) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
EyePoint Pharmaceuticals Inc Stock Analysis and ForecastCandlestick Pattern Analysis & Consistently Superior Profits - earlytimes.in
With 57% institutional ownership, EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) is a favorite amongst the big guns - Yahoo Finance
Will EyePoint Pharmaceuticals Inc. stock outperform growth indexesTrade Risk Report & Free High Return Stock Watch Alerts - newser.com
EyePoint Pharmaceuticals to Host Conference Call for Q3 2025 Financial Results on November 5, 2025 - Quiver Quantitative
EyePoint to Report Third Quarter 2025 Financial Results on November 5, 2025 - The Manila Times
EyePoint Pharmaceuticals (NASDAQ: EYPT) sets 8:30 a.m. ET call to discuss Q3 results - Stock Titan
大文字化:
|
ボリューム (24 時間):